1,2-dimethylhydrazine multiple interactions ISO RGD:1622415 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATP6V1A mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1622415 6480464 Ethinyl Estradiol results in increased expression of ATP6V1A mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1323585 6480464 [Progesterone co-treated with Estradiol] results in increased expression of ATP6V1A mRNA CTD PMID:17404688 17beta-estradiol increases expression ISO RGD:1622415 6480464 Estradiol results in increased expression of ATP6V1A mRNA CTD PMID:15289156 2,2,2-tetramine decreases expression EXP 6480464 Trientine results in decreased expression of ATP6V1A protein CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1622415 6480464 Tetrachlorodibenzodioxin affects the expression of ATP6V1A mRNA CTD PMID:21570461 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1622415 6480464 2 more ... CTD PMID:18550172 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:1622415 6480464 Butylated Hydroxytoluene inhibits the reaction [Reactive Oxygen Species results in decreased expression of ATP6V1A protein] CTD PMID:12470298 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:1323585 6480464 Butylated Hydroxytoluene inhibits the reaction [TNF protein results in decreased expression of ATP6V1A protein] CTD PMID:12470298 3-chloropropane-1,2-diol decreases expression ISO RGD:1323585 6480464 alpha-Chlorohydrin results in decreased expression of ATP6V1A mRNA CTD PMID:32702505 4-hydroxynon-2-enal increases expression ISO RGD:1622415 6480464 4-hydroxy-2-nonenal results in increased expression of ATP6V1A mRNA CTD PMID:19191707 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of ATP6V1A mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of ATP6V1A mRNA CTD PMID:19483382 aflatoxin B1 decreases methylation ISO RGD:1323585 6480464 Aflatoxin B1 results in decreased methylation of ATP6V1A gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1323585 6480464 Aflatoxin B1 results in increased expression of ATP6V1A mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1323585 6480464 Tretinoin results in increased expression of ATP6V1A mRNA CTD PMID:16054129 all-trans-retinoic acid decreases expression ISO RGD:1323585 6480464 Tretinoin results in decreased expression of ATP6V1A mRNA CTD PMID:15498508 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of ATP6V1A mRNA CTD PMID:19483382 antirheumatic drug decreases expression ISO RGD:1323585 6480464 Antirheumatic Agents results in decreased expression of ATP6V1A mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1323585 6480464 aristolochic acid I results in increased expression of ATP6V1A protein CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1622415 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ATP6V1A mRNA CTD PMID:23650126 arsenous acid increases expression ISO RGD:1323585 6480464 Arsenic Trioxide results in increased expression of ATP6V1A mRNA CTD PMID:20458559 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of ATP6V1A mRNA CTD PMID:19483382 benzo[a]pyrene increases expression ISO RGD:1622415 6480464 Benzo(a)pyrene results in increased expression of ATP6V1A mRNA CTD PMID:19770486 more ... benzo[a]pyrene affects methylation ISO RGD:1323585 6480464 Benzo(a)pyrene affects the methylation of ATP6V1A intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1323585 6480464 7 more ... CTD PMID:20018196 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ATP6V1A mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1323585 6480464 bisphenol A results in decreased expression of ATP6V1A protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:1323585 6480464 bisphenol A results in decreased methylation of ATP6V1A gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP6V1A mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:1323585 6480464 bisphenol A results in increased expression of ATP6V1A mRNA CTD PMID:29275510 bisphenol A decreases expression ISO RGD:1622415 6480464 bisphenol A results in decreased expression of ATP6V1A protein CTD PMID:28641223 Bisphenol B increases expression ISO RGD:1323585 6480464 bisphenol B results in increased expression of ATP6V1A protein CTD PMID:34186270 bleomycin A2 multiple interactions ISO RGD:1622415 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ATP6V1A protein CTD PMID:29733421 bleomycin A2 decreases expression ISO RGD:1622415 6480464 Bleomycin results in decreased expression of ATP6V1A protein CTD PMID:29733421 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of ATP6V1A protein CTD PMID:28903499 butylated hydroxyanisole multiple interactions ISO RGD:1323585 6480464 Butylated Hydroxyanisole inhibits the reaction [TNF protein results in decreased expression of ATP6V1A protein] CTD PMID:12470298 butylated hydroxyanisole multiple interactions ISO RGD:1622415 6480464 Butylated Hydroxyanisole inhibits the reaction [Reactive Oxygen Species results in decreased expression of ATP6V1A protein] CTD PMID:12470298 cadmium dichloride increases expression ISO RGD:1323585 6480464 Cadmium Chloride results in increased expression of ATP6V1A mRNA, Cadmium Chloride results in increased expression of ATP6V1A protein CTD PMID:24527689 , PMID:26472689 cadmium dichloride increases expression ISO RGD:1622415 6480464 Cadmium Chloride results in increased expression of ATP6V1A mRNA CTD PMID:30030080 calcitriol decreases expression ISO RGD:1323585 6480464 Calcitriol results in decreased expression of ATP6V1A mRNA CTD PMID:12798352 cannabidiol multiple interactions ISO RGD:1323585 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of ATP6V1A protein CTD PMID:34122009 carbon nanotube increases expression ISO RGD:1622415 6480464 Nanotubes, Carbon analog results in increased expression of ATP6V1A mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1323585 6480464 CGP 52608 promotes the reaction [RORA protein binds to ATP6V1A gene] CTD PMID:28238834 cisplatin affects response to substance ISO RGD:1323585 6480464 ATP6V1A mRNA affects the susceptibility to Cisplatin CTD PMID:18610736 cisplatin multiple interactions ISO RGD:1622415 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ATP6V1A protein CTD PMID:29733421 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of ATP6V1A mRNA CTD PMID:19483382 clozapine decreases expression ISO RGD:1323585 6480464 Clozapine results in decreased expression of ATP6V1A protein CTD PMID:34122009 cobalt dichloride increases expression ISO RGD:1323585 6480464 cobaltous chloride results in increased expression of ATP6V1A mRNA CTD PMID:19376846 cobalt dichloride decreases expression ISO RGD:1323585 6480464 cobaltous chloride results in decreased expression of ATP6V1A mRNA CTD PMID:17553155 copper(II) sulfate increases expression ISO RGD:1323585 6480464 Copper Sulfate results in increased expression of ATP6V1A mRNA CTD PMID:19549813 CU-O LINKAGE increases expression ISO RGD:1323585 6480464 cupric oxide results in increased expression of ATP6V1A mRNA CTD PMID:22077320 Cuprizon multiple interactions ISO RGD:1323585 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of ATP6V1A protein CTD PMID:34122009 cyclosporin A decreases expression ISO RGD:1323585 6480464 Cyclosporine results in decreased expression of ATP6V1A mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:1622415 6480464 Cyclosporine results in decreased expression of ATP6V1A mRNA CTD PMID:19770486 deoxynivalenol decreases expression ISO RGD:1323585 6480464 deoxynivalenol results in decreased expression of ATP6V1A protein CTD PMID:33890134 diarsenic trioxide increases expression ISO RGD:1323585 6480464 Arsenic Trioxide results in increased expression of ATP6V1A mRNA CTD PMID:20458559 diethylstilbestrol increases expression ISO RGD:1622415 6480464 Diethylstilbestrol results in increased expression of ATP6V1A mRNA CTD PMID:15289156 doxorubicin decreases expression ISO RGD:1323585 6480464 Doxorubicin results in decreased expression of ATP6V1A mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO RGD:1323585 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATP6V1A protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:1622415 6480464 epoxiconazole results in decreased expression of ATP6V1A mRNA CTD PMID:35436446 ethanol affects splicing ISO RGD:1622415 6480464 Ethanol affects the splicing of ATP6V1A mRNA CTD PMID:30319688 etoposide multiple interactions ISO RGD:1622415 6480464 [Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of ATP6V1A protein CTD PMID:29733421 etoposide decreases expression ISO RGD:1622415 6480464 Etoposide results in decreased expression of ATP6V1A protein CTD PMID:29733421 finasteride increases expression EXP 6480464 Finasteride results in increased expression of ATP6V1A mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ATP6V1A mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1622415 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATP6V1A mRNA CTD PMID:22206623 genistein increases expression ISO RGD:1622415 6480464 Genistein results in increased expression of ATP6V1A mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ATP6V1A mRNA CTD PMID:22061828 , PMID:33387578 ivermectin decreases expression ISO RGD:1323585 6480464 Ivermectin results in decreased expression of ATP6V1A protein CTD PMID:32959892 L-ascorbic acid increases expression ISO RGD:1622415 6480464 Ascorbic Acid results in increased expression of ATP6V1A mRNA CTD PMID:22139585 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of ATP6V1A mRNA CTD PMID:19483382 lead diacetate affects expression ISO RGD:1622415 6480464 lead acetate affects the expression of ATP6V1A protein CTD PMID:20797405 leflunomide increases expression ISO RGD:1323585 6480464 leflunomide results in increased expression of ATP6V1A mRNA CTD PMID:28988120 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of ATP6V1A mRNA CTD PMID:28801915 mercury atom decreases expression ISO RGD:1323585 6480464 Mercury results in decreased expression of ATP6V1A mRNA CTD PMID:16823088 mercury(0) decreases expression ISO RGD:1323585 6480464 Mercury results in decreased expression of ATP6V1A mRNA CTD PMID:16823088 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ATP6V1A mRNA CTD PMID:28801915 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of ATP6V1A protein CTD PMID:19716841 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of ATP6V1A mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1323585 6480464 Nickel results in decreased expression of ATP6V1A mRNA CTD PMID:23195993 nickel sulfate decreases expression ISO RGD:1323585 6480464 nickel sulfate results in decreased expression of ATP6V1A mRNA CTD PMID:18651567 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of ATP6V1A mRNA CTD PMID:19483382 paclitaxel affects response to substance ISO RGD:1323585 6480464 ATP6V1A protein affects the susceptibility to Paclitaxel CTD PMID:16217747 phenobarbital affects expression ISO RGD:1622415 6480464 Phenobarbital affects the expression of ATP6V1A mRNA CTD PMID:23091169 pirinixic acid increases expression ISO RGD:1622415 6480464 pirinixic acid results in increased expression of ATP6V1A mRNA CTD PMID:16221962 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of ATP6V1A mRNA CTD PMID:19483382 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ATP6V1A mRNA CTD PMID:19162173 progesterone multiple interactions ISO RGD:1323585 6480464 [Progesterone co-treated with Estradiol] results in increased expression of ATP6V1A mRNA CTD PMID:17404688 propiconazole increases expression ISO RGD:1622415 6480464 propiconazole results in increased expression of ATP6V1A mRNA CTD PMID:21278054 reactive oxygen species multiple interactions ISO RGD:1622415 6480464 Butylated Hydroxyanisole inhibits the reaction [Reactive Oxygen Species results in decreased expression of ATP6V1A protein], Butylated Hydroxytoluene inhibits the reaction [Reactive Oxygen Species results in decreased expression of ATP6V1A protein] CTD PMID:12470298 reactive oxygen species decreases expression ISO RGD:1622415 6480464 Reactive Oxygen Species results in decreased expression of ATP6V1A protein CTD PMID:12470298 resveratrol multiple interactions ISO RGD:1323585 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1A mRNA CTD PMID:23557933 rotenone increases expression ISO RGD:1323585 6480464 Rotenone results in increased expression of ATP6V1A mRNA CTD PMID:31648047 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of ATP6V1A mRNA CTD PMID:22431001 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ATP6V1A protein CTD PMID:29459688 sodium arsenite increases expression ISO RGD:1622415 6480464 sodium arsenite results in increased expression of ATP6V1A mRNA CTD PMID:36209798 sulindac increases expression EXP 6480464 Sulindac results in increased expression of ATP6V1A mRNA CTD PMID:24136188 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of ATP6V1A protein CTD PMID:26141394 tamibarotene affects expression ISO RGD:1323585 6480464 tamibarotene affects the expression of ATP6V1A mRNA CTD PMID:15498508 temozolomide decreases expression ISO RGD:1323585 6480464 Temozolomide results in decreased expression of ATP6V1A mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:1323585 6480464 tert-Butylhydroperoxide results in decreased expression of ATP6V1A mRNA CTD PMID:15336504 testosterone enanthate affects expression ISO RGD:1323585 6480464 testosterone enanthate affects the expression of ATP6V1A mRNA CTD PMID:17440010 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of ATP6V1A mRNA CTD PMID:19483382 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ATP6V1A mRNA CTD PMID:34492290 trichloroethene increases expression ISO RGD:1622415 6480464 Trichloroethylene results in increased expression of ATP6V1A mRNA CTD PMID:19448997 trichostatin A affects expression ISO RGD:1323585 6480464 trichostatin A affects the expression of ATP6V1A mRNA CTD PMID:28542535 triptonide affects expression ISO RGD:1622415 6480464 triptonide affects the expression of ATP6V1A mRNA CTD PMID:33045310 uranium atom affects expression ISO RGD:1323585 6480464 Uranium affects the expression of ATP6V1A mRNA CTD PMID:15672453 valproic acid decreases methylation ISO RGD:1323585 6480464 Valproic Acid results in decreased methylation of ATP6V1A gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1323585 6480464 Valproic Acid results in increased expression of ATP6V1A mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1323585 6480464 Valproic Acid affects the expression of ATP6V1A mRNA CTD PMID:25979313 vanadium atom increases expression ISO RGD:1323585 6480464 Vanadium results in increased expression of ATP6V1A mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:1323585 6480464 Vanadium results in increased expression of ATP6V1A mRNA CTD PMID:19000753 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ATP6V1A mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ATP6V1A mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:1323585 6480464 vorinostat results in increased expression of ATP6V1A mRNA CTD PMID:27188386
